Your session is about to expire
← Back to Search
Xanomeline and Trospium Chloride Capsules for Schizophrenia
Study Summary
This study is evaluating whether a drug called KarXT may help reduce symptoms of schizophrenia.
- Schizophrenia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 252 Patients • NCT04659161Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many test subjects are needed for this experiment?
"Unfortunately, this study is not currently enrolling patients. The trial was first posted on April 6th 2021 and updated November 11th 2022. There are other trials related to schizophrenia that are recruiting 349 participants and 5 trials for Xanomeline and Trospium Chloride Capsules looking for willing enrollees."
how many different medical facilities are hosting this research project?
"Patients can enroll at Larkin Behavioral Health Services in Hollywood, Florida, Collaborative Neuroscience Research, LLC. in Garden Grove, California, and CNS Network in Long Beach, Texas as well as 18 other locations."
Does this trial have an age limit and, if so, what is it?
"The target enrollment for this clinical trial are individuals that are over 18 but have not yet reached 65 years old."
Would I be able to qualify for this medical research program?
"We are looking for 246 individuals with schizophrenia that fall within the ages of 18-65. The following must also be met: needing hospitalization due to a recent relapse or exacerbation of psychotic symptoms (within 2 months of screening), being hospitalized for less than 2 weeks at the time of screening, and item 2 on the P2 scale."
Do people experience many negative side effects from taking Xanomeline and Trospium Chloride Capsules?
"There is some efficacy data and multiple rounds of safety data from Phase 3 trials, so our team at Power rates the safety of Xanomeline and Trospium Chloride Capsules as a 3."
Are Xanomeline and Trospium Chloride Capsules new medications?
"There are 5 ongoing clinical trials evaluating the efficacy of Xanomeline and Trospium Chloride Capsules. 4 of these trials have reached Phase 3. Although many of the trials are situated in Riverside, California, there are a total 159 locations running these clinical trials."
Is it possible to sign up for this experiment at the moment?
"No, this particular study is not searching for new participants as of right now. However, it is worth noting that there are other 354 clinical trials actively recruiting patients."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger